98 related articles for article (PubMed ID: 1959611)
1. Kirromycin-induced modifications facilitate the separation of EF-Tu species and reveal intermolecular interactions.
Anborgh PH; Swart GW; Parmeggiani A
FEBS Lett; 1991 Nov; 292(1-2):232-6. PubMed ID: 1959611
[TBL] [Abstract][Full Text] [Related]
2. Effects of the mutation glycine-222----aspartic acid on the functions of elongation factor Tu.
Swart GW; Parmeggiani A; Kraal B; Bosch L
Biochemistry; 1987 Apr; 26(7):2047-54. PubMed ID: 3297141
[TBL] [Abstract][Full Text] [Related]
3. Molecular properties of two mutant species of the elongation factor Tu.
Van der Meide PH; Duisterwinkel FJ; De Graaf JM; Kraal B; Bosch L; Douglass J; Blumenthal T
Eur J Biochem; 1981 Jun; 117(1):1-6. PubMed ID: 7021152
[TBL] [Abstract][Full Text] [Related]
4. Altered regulation of the guanosine 5'-triphosphate activity in a kirromycin-resistant elongation factor Tu.
Fasano O; Parmeggiani A
Biochemistry; 1981 Mar; 20(5):1361-6. PubMed ID: 6112013
[TBL] [Abstract][Full Text] [Related]
5. Effects of the antibiotic pulvomycin on the elongation factor Tu-dependent reactions. Comparison with other antibiotics.
Anborgh PH; Okamura S; Parmeggiani A
Biochemistry; 2004 Dec; 43(49):15550-6. PubMed ID: 15581367
[TBL] [Abstract][Full Text] [Related]
6. Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu.
Wolf H; Chinali G; Parmeggiani A
Proc Natl Acad Sci U S A; 1974 Dec; 71(12):4910-4. PubMed ID: 4373734
[TBL] [Abstract][Full Text] [Related]
7. The interaction between aminoacyl-tRNA and the mutant elongation factors Tu AR and B0.
Abrahams JP; Acampo JJ; Ott G; Sprinzl M; de Graaf JM; Talens A; Kraal B
Biochim Biophys Acta; 1990 Aug; 1050(1-3):226-9. PubMed ID: 2207147
[TBL] [Abstract][Full Text] [Related]
8. Mutations to kirromycin resistance occur in the interface of domains I and III of EF-Tu.GTP.
Abdulkarim F; Liljas L; Hughes D
FEBS Lett; 1994 Sep; 352(2):118-22. PubMed ID: 7925958
[TBL] [Abstract][Full Text] [Related]
9. Isolation, crystallization and X-ray analysis of the quaternary complex of Phe-tRNA(Phe), EF-Tu, a GTP analog and kirromycin.
Kristensen O; Reshetnikova L; Nissen P; Siboska G; Thirup S; Nyborg J
FEBS Lett; 1996 Dec; 399(1-2):59-62. PubMed ID: 8980119
[TBL] [Abstract][Full Text] [Related]
10. Elongation factor Tu resistant to kirromycin in an Escherichia coli mutant altered in both tuf genes.
Fischer E; Wolf H; Hantke K; Parmeggiani A
Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4341-5. PubMed ID: 337296
[TBL] [Abstract][Full Text] [Related]
11. Enacyloxin IIa pinpoints a binding pocket of elongation factor Tu for development of novel antibiotics.
Parmeggiani A; Krab IM; Watanabe T; Nielsen RC; Dahlberg C; Nyborg J; Nissen P
J Biol Chem; 2006 Feb; 281(5):2893-900. PubMed ID: 16257965
[TBL] [Abstract][Full Text] [Related]
12. Elongation factor Tu isolated from Escherichia coli mutants altered in TufA and tufB.
Van der Meide PH; Borman TH; Van Kimmenade AM; Van de Putte P; Bosch L
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):3922-6. PubMed ID: 7001448
[TBL] [Abstract][Full Text] [Related]
13. Q beta replicase containing wild type and mutant tufA and tufB gene.
Blumenthal T; Saari B; Van der Meide PH; Bosch L
J Biol Chem; 1980 Jun; 255(11):5300-5. PubMed ID: 6989824
[TBL] [Abstract][Full Text] [Related]
14. Mg2+ is not catalytically required in the intrinsic and kirromycin-stimulated GTPase action of Thermus thermophilus EF-Tu.
Rutthard H; Banerjee A; Makinen MW
J Biol Chem; 2001 Jun; 276(22):18728-33. PubMed ID: 11274193
[TBL] [Abstract][Full Text] [Related]
15. Elongation factor Tu1 of the antibiotic GE2270A producer Planobispora rosea has an unexpected resistance profile against EF-Tu targeted antibiotics.
Möhrle VG; Tieleman LN; Kraal B
Biochem Biophys Res Commun; 1997 Jan; 230(2):320-6. PubMed ID: 9016775
[TBL] [Abstract][Full Text] [Related]
16. Kirromycin drastically reduces the affinity of Escherichia coli elongation factor Tu for aminoacyl-tRNA.
Abrahams JP; van Raaij MJ; Ott G; Kraal B; Bosch L
Biochemistry; 1991 Jul; 30(27):6705-10. PubMed ID: 2065055
[TBL] [Abstract][Full Text] [Related]
17. Mutant ribosomes can generate dominant kirromycin resistance.
Tubulekas I; Buckingham RH; Hughes D
J Bacteriol; 1991 Jun; 173(12):3635-43. PubMed ID: 2050625
[TBL] [Abstract][Full Text] [Related]
18. A mutant elongation factor Tu which does not immobilize the ribosome upon binding of kirromycin.
Duisterwinkel FJ; De Graaf JM; Schretlen PJ; Kraal B; Bosch L
Eur J Biochem; 1981 Jun; 117(1):7-12. PubMed ID: 7021158
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the elongation factors from calf brain. 2. Functional properties of EF-1 alpha, the action of physiological ligands and kirromycin.
Crechet JB; Parmeggiani A
Eur J Biochem; 1986 Dec; 161(3):647-53. PubMed ID: 3641717
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a kirromycin-resistant elongation factor Tu from Escherichia coli.
Ivell R; Fasano O; Crechet JB; Parmeggiani A
Biochemistry; 1981 Mar; 20(5):1355-61. PubMed ID: 7013793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
